Lentivirus-mediated overexpression of OTULIN ameliorates microglia activation and neuroinflammation by depressing the activation of the NF-κB signaling pathway in cerebral ischemia/reperfusion rats

Abstract

BackgroundIschemic stroke-induced neuroinflammation is mainly mediated by microglial cells. The nuclear factor kappa B (NF-κB) pathway is the key transcriptional pathway that initiates inflammatory responses following cerebral ischemia. OTULIN, a critical negative regulator of the NF-κΒ signaling pathway, exerts robust effects on peripheral immune cell-mediated inflammation and is regarded as an essential mediator for repressing inflammation in vivo. The effect of OTULIN on inflammatory responses in the central nervous system (CNS) was previously unstudied. This current study investigated the anti-inflammatory effect of OTULIN both in vitro and in vivo in ischemic stroke models.MethodsSprague-Dawley (SD) rats were subjected to transient middle cerebral artery occlusion (tMCAO) or an intraperitoneal injection of lipopolysaccharide (LPS). Overexpression of the OTULIN gene was utilized to observe the effect of OTULIN on ischemic stroke outcomes. The effect of OTULIN overexpression on microglia-mediated neuroinflammation was examined in rat primary microglia (PM) and in the microglial cell line N9 after induction by oxygen-glucose deprivation (OGD)-treated neuronal medium. The activation and inflammatory responses of microglia were detected using immunofluorescence, ELISA, and qRT-PCR. The details of molecular mechanism were assessed using Western blotting.ResultsIn the tMCAO rats, the focal cerebral ischemia/reperfusion injury induced a continuous increase in OTULIN expression within 72 h, and OTULIN expression was increased in activated microglial cells. OTULIN overexpression obviously decreased the cerebral infarct volume, improved the neurological function deficits, and reduced neuronal loss at 72 h after reperfusion, and it also inhibited the activation of microglia and attenuated the release of TNF-α, IL-1β, and IL-6 by suppressing the NF-κB pathway at 24 h after tMCAO. In vitro, OTULIN overexpression inhibited the microglia-mediated neuroinflammation by reducing the production of TNF-α, IL-1β, and IL-6 via depressing the NF-κB pathway in both PM and N9 cells.ConclusionsOTULIN provides a potential therapeutic target for ischemic brain injury by ameliorating the excessive activation of microglial cells and neuroinflammation through repressing the NF-κB signaling pathway.Electronic supplementary materialThe online version of this article (10.1186/s12974-018-1117-5) contains supplementary material, which is available to authorized users.

HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways

“…Immunity and inflammation are key elements that contribute to the pathobiology of stroke, and its caused-CI/RI and the secondary damage to brain tissues are closely associated with immunity and inflammation responses [5,6,7,8]. Previous research has shown that immunity and inflammation are integral parts of the pathogenesis of ischemic stroke [55,56,57]. Inflammatory signaling is activated and completed by blood-borne leukocytes that penetrate the brain during the ischemic phase [2].…”

Protective Effects and Target Network Analysis of Ginsenoside Rg1 in Cerebral Ischemia and Reperfusion Injury: A Comprehensive Overview of Experimental Studies

“…Increasing evidence has indicated that an inflammatory response is involved in all stages of ischemia-reperfusion injury [68,69]. Once ischemia/reperfusion occurs, ROS production promotes the activation of complements, platelets and endothelial cells; activates inflammatory transcription factors and the release inflammatory signals [70]; and generates inflammatory factors, including IL-6, IL-1β, and TNF-α [68,69,70,71]. At the same time, because ROS causes neuronal cell death and the release of nucleosides, they can activate purine receptors on microglia and macrophages, leading to the aggregation of and infiltration by inflammatory cells to simultaneously induce inflammation and a series of secondary tissue damage, such as the destruction of the blood-brain barrier and cerebral edema [15,43,72].…”

Protective effects of leptin against cerebral ischemia/reperfusion injury (Review)

“…In addition, neutrophil adhesion to vascular endothelial cells inhibited the production of NO, as determined by the aggravation of cell edema (74). Leptin has an anti-inflammatory role (75,76); it activates the nuclear factor-κB pathway, inhibits the expression of pro-inflammatory factors [tumor necrosis factor (TNF)-α, IL-6, IL-1β] within 7 h and increases the expression of IL-10 (74,77) Within 100 min, the human body is able to recover from hypothermia and hypotension caused by ischemia/reperfusion injury (78). Within 90–240 min, TNF-α is inhibited.…”